Feinstein Kean Healthcare
Feinstein Kean Healthcare (FKH) is the preeminent strategy/communication partner for world-class organizations that are transforming life sciences and medicine in the 21st century. In 2012, FKH will be a 25-year old firm. We are headquartered in Cambridge, Massachusetts, with satellite teams in New Jersey, Washington, DC and San Francisco. FKH is an Ogilvy company, and participates globally with its Ogilvy colleagues to provide services to clients on a global basis.
The firm was founded in the earliest days of the biotech revolution, and was a pioneer in establishing strategic practices for communications (corporate communications, marketing, public relations and investor relations) in that formative era. To maintain its leadership and vision, FKH established the country’s first Molecular Medicine practice in 2004, which has served clients such as the National Cancer Institute; diagnostics and therapeutic innovators; policy organizations such as the Personalized Medicine Coalition and PhRMA; and prestigious educational institutions such as Harvard, MIT and Duke.
FKH has a full range of services that help clients to drive commercialization of their products, form partnerships, build coalitions with stakeholders, and improve the landscape with impact on policy.
Today, FKH has clients from the government, pharmaceutical, diagnostic, biotech, non-profit, and academic sectors. The firm is once again breaking new ground, positioned at the intersection where innovative approaches, transformative technologies and ideas affect business models, public policy, and public opinion for the life sciences and healthcare sectors.